Veterinary and Comparative Oncology

Cover image for Vol. 14 Issue 3

Early View (Online Version of Record published before inclusion in an issue)

Edited By: David J. Argyle and Douglas H. Thamm

Impact Factor: 2.452

ISI Journal Citation Reports © Ranking: 2015: 9/138 (Veterinary Sciences)

Online ISSN: 1476-5829

VIEW

  1. 1 - 100
  2. 101 - 127
  1. Original Articles

    1. Retrospective evaluation of COX-2 expression, histological and clinical factors as prognostic indicators in dogs with renal cell carcinomas undergoing nephrectomy

      S. Carvalho, A. L. Stoll, S. L. Priestnall, A. Suarez-Bonnet, K. Rassnick, S. Lynch, I. Schoepper, G. Romanelli, P. Buracco, M. Atherton, E. M. de Merlo and A. Lara-Garcia

      Version of Record online: 31 AUG 2016 | DOI: 10.1111/vco.12264

    2. Evaluation of Pax5 expression and comparison with BLA.36 and CD79αcy in feline non-Hodgkin lymphoma

      R. Felisberto, J. Matos, M. Alves, J. Cabeçadas and J. Henriques

      Version of Record online: 22 AUG 2016 | DOI: 10.1111/vco.12262

  2. Invited Reviews

    1. You have free access to this content
      Gastric carcinoma in canines and humans, a review

      S. Hugen, R. E. Thomas, A. J. German, I. A. Burgener and P. J. J. Mandigers

      Version of Record online: 22 AUG 2016 | DOI: 10.1111/vco.12249

  3. Original Articles

    1. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy

      K. M. Curran, P. A. Schaffer, C. B. Frank, S. E. Lana, L. E. Hamil, J. H. Burton, J. Labadie, E. J. Ehrhart and P. R. Avery

      Version of Record online: 11 AUG 2016 | DOI: 10.1111/vco.12263

    2. Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer

      L. Cicchelero, S. Denies, H. Haers, K. Vanderperren, E. Stock, L. Van Brantegem, H. de Rooster and N. N. Sanders

      Version of Record online: 9 AUG 2016 | DOI: 10.1111/vco.12255

    3. IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells

      K. Bauer, E. Hadzijusufovic, S. Cerny-Reiterer, G. Hoermann, M. Reifinger, A. Pirker, P. Valent and M. Willmann

      Version of Record online: 9 AUG 2016 | DOI: 10.1111/vco.12260

    4. A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics

      A. Pawlak, E. Ziolo, J. Kutkowska, A. Blazejczyk, J. Wietrzyk, A. Krupa, W. Hildebrand, P. Dziegiel, S. Dzimira, B. Obminska-Mrukowicz, L. Strzadala and A. Rapak

      Version of Record online: 9 AUG 2016 | DOI: 10.1111/vco.12257

    5. You have full text access to this OnlineOpen article
    6. Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature

      L. Marconato, G. A. Polton, S. Sabattini, M. Dacasto, O. A. Garden, I. Grant, T. Hendrickx, J. Henriques, G. Lubas, E. Morello, D. Stefanello, S. Comazzi and on behalf of the European Canine Lymphoma Network

      Version of Record online: 14 JUL 2016 | DOI: 10.1111/vco.12244

    7. Canine acute leukaemia: 50 cases (1989–2014)

      A. L. Bennett, L. E. Williams, M. W. Ferguson, M. L. Hauck, S. E. Suter, C. B. Lanier and P. R. Hess

      Version of Record online: 12 JUL 2016 | DOI: 10.1111/vco.12251

    8. Properties of the feline tumour suppressor reduced expression in immortalized cells (REIC/Dkk-3)

      K. Ochiai, H. Oda, S. Shono, Y. Kato, S. Sugihara, S. Nakazawa, D. Azakami, M. Michishita, E. Onozawa, M. Bonkobara, T. Sako, L. Shun-Ai, H. Ueki, M. Watanabe and T. Omi

      Version of Record online: 29 JUN 2016 | DOI: 10.1111/vco.12254

    9. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53

      D. York, S. S. Withers, K. D. Watson, K. W. Seo and R. B. Rebhun

      Version of Record online: 23 JUN 2016 | DOI: 10.1111/vco.12250

    10. Clinical prognostic factors in canine histiocytic sarcoma

      N. G. Dervisis, M. Kiupel, Q. Qin and L. Cesario

      Version of Record online: 23 JUN 2016 | DOI: 10.1111/vco.12252

    11. Expression of VEGFR and PDGFR-α/-β in 187 canine nasal carcinomas

      I. Gramer, D. Killick, T. Scase, D. Chandry, M. Marrington and L. Blackwood

      Version of Record online: 9 JUN 2016 | DOI: 10.1111/vco.12245

    12. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours

      S. Sabattini, G. Barzon, M. Giantin, R. M. Lopparelli, M. Dacasto, D. Prata and G. Bettini

      Version of Record online: 9 JUN 2016 | DOI: 10.1111/vco.12246

    13. Outcome in dogs with advanced (stage 3b) anal sac gland carcinoma treated with surgery or hypofractionated radiation therapy

      V. Meier, G. Polton, S. Cancedda, M. Roos, P. Laganga, T. Emmerson and C. Rohrer Bley

      Version of Record online: 9 JUN 2016 | DOI: 10.1111/vco.12248

    14. You have full text access to this OnlineOpen article
      Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro

      M. E. Gray, S. Lee, A. L. McDowell, M. Erskine, Q. T. M. Loh, O. Grice, D. J. Argyle and G. T. Bergkvist

      Version of Record online: 27 MAY 2016 | DOI: 10.1111/vco.12230

    15. Association of breed and histopathological grade in canine mast cell tumours

      H. Mochizuki, A. Motsinger-Reif, C. Bettini, S. Moroff and M. Breen

      Version of Record online: 19 MAY 2016 | DOI: 10.1111/vco.12225

    16. Extravasation reactions associated with the administration of pamidronate: 11 cases (2008–2013)

      B. A. Marker, L. G. Barber, C. A. Clifford, S. S. Correa, P. L. Thalhofer, T. A. LaDue, C. M. Mullin, M. L. Sauerbrey and C. C. Wood

      Version of Record online: 13 MAY 2016 | DOI: 10.1111/vco.12191

    17. Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer

      S. Caceres, L. Peña, L. Lacerda, M. J. Illera, P. J. de Andres, R. A. Larson, H. Gao, B. G. Debeb, W. A. Woodward, J. M. Reuben and J. C. Illera

      Version of Record online: 5 MAY 2016 | DOI: 10.1111/vco.12238

    18. Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding study

      M. A. Pellin, R. M. Wouda, K. Robinson, K. Tsimbas, I. D. Kurzman, B. J. Biller and D. M. Vail

      Version of Record online: 5 MAY 2016 | DOI: 10.1111/vco.12232

    19. Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination

      L. A. Piras, F. Riccardo, S. Iussich, L. Maniscalco, F. Gattino, M. Martano, E. Morello, S. Lorda Mayayo, V. Rolih, F. Garavaglia, R. De Maria, E. Lardone, F. Collivignarelli, D. Mignacca, D. Giacobino, S. Ferrone, F. Cavallo and P. Buracco

      Version of Record online: 4 MAY 2016 | DOI: 10.1111/vco.12239

    20. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT

      L. R. Raposo, C. Roma-Rodrigues, P. Faísca, M. Alves, J. Henriques, M. C. Carvalheiro, M. L. Corvo, P. V. Baptista, A. J Pombeiro and A. R. Fernandes

      Version of Record online: 3 MAY 2016 | DOI: 10.1111/vco.12235

    21. Evaluation of the global DNA methylation in canine mast cell tumour samples by immunostaining of 5-methyl cytosine

      C. Y. Morimoto, M. V. Tedardi, I. I. M. da Fonseca, K. C. Kimura, D. S. Sanches, T. F. Epiphanio, R. de Francisco Strefezzi and M. L. Z. Dagli

      Version of Record online: 3 MAY 2016 | DOI: 10.1111/vco.12241

  4. Invited Reviews

    1. You have free access to this content
      Quality of life assessment in dogs and cats receiving chemotherapy – a review of current methods

      Kåre K. Vøls, Martin A. Heden, Annemarie T. Kristensen and Peter Sandøe

      Version of Record online: 3 MAY 2016 | DOI: 10.1111/vco.12242

  5. Original Articles

    1. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil

      K. F. Castro, A. Strakova, M. Tinucci-Costa and E. P. Murchison

      Version of Record online: 2 MAY 2016 | DOI: 10.1111/vco.12205

  6. Short Communications

    1. Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphoma

      R. Mani, R. Yan, X. Mo, C.-S. Chen, M. A. Phelps, R. Klisovic, J. C. Byrd, W. C. Kisseberth, C. A. London and N. Muthusamy

      Version of Record online: 2 MAY 2016 | DOI: 10.1111/vco.12221

  7. Original Articles

  8. Invited Reviews

    1. You have free access to this content
      Proteases as prognostic markers in human and canine cancers

      L. H. Pulz and R. F. Strefezzi

      Version of Record online: 2 MAY 2016 | DOI: 10.1111/vco.12223

  9. Original Articles

    1. Integrated immunohistochemical and DNA copy number profiling analysis provides insight into the molecular pathogenesis of canine follicular lymphoma

      R. Thomas, Z. Demeter, K. A. Kennedy, L. Borst, K. Singh, V. E. Valli, K. Le Boedec and M. Breen

      Version of Record online: 2 MAY 2016 | DOI: 10.1111/vco.12227

    2. DNA methylation and targeted sequencing of methyltransferases family genes in canine acute myeloid leukaemia, modelling human myeloid leukaemia

      I. Bronzini, L. Aresu, M. Paganin, L. Marchioretto, S. Comazzi, F. Cian, F. Riondato, L. Marconato, V. Martini and G. te Kronnie

      Version of Record online: 21 APR 2016 | DOI: 10.1111/vco.12231

    3. Febrile neutropenia in cats treated with chemotherapy

      J. Pierro, E. Krick, A. Flory, R. Regan, C. DeRegis, B. Boudreaux, L. Barber, D. Saam and C. Saba

      Version of Record online: 20 APR 2016 | DOI: 10.1111/vco.12198

    4. Production and characterization of monoclonal antibodies specific for canine CD138 (syndecan-1) for nuclear medicine preclinical trials on spontaneous tumours

      M. Diab, F. Nguyen, M. Berthaud, C. Maurel, J. Gaschet, E. Verger, C. Ibisch, C. Rousseau, M. Chérel, J. Abadie and F. Davodeau

      Version of Record online: 14 APR 2016 | DOI: 10.1111/vco.12233

  10. Letters to the Editor

  11. Original Articles

    1. The effects of sulforaphane on canine osteosarcoma proliferation and invasion

      V. L. Rizzo, C. B. Levine and J. J. Wakshlag

      Version of Record online: 4 APR 2016 | DOI: 10.1111/vco.12212

    2. Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats

      C. H. Merrick, J. Pierro, S. E. Schleis, E. A. Sones, Z. M. Wright, R. C. Regan, C. T. Siedlecki and P. J. Bergman

      Version of Record online: 4 APR 2016 | DOI: 10.1111/vco.12211

    3. Differential expression of microRNAs in bovine papillomavirus type 1 transformed equine cells

      N. Terron-Canedo, W. Weir, L. Nicolson, C. Britton and L. Nasir

      Version of Record online: 4 APR 2016 | DOI: 10.1111/vco.12216

    4. Increased expression of tissue inhibitor of metalloproteinase-1 correlates with improved outcome in canine cutaneous mast cell tumours

      L. H. Pulz, C. N. Barra, S. R. Kleeb, J. G. Xavier, J. L. Catão-Dias, R. A. Sobral, H. Fukumasu and R. F. Strefezzi

      Version of Record online: 4 APR 2016 | DOI: 10.1111/vco.12204

    5. Clinical presentation, treatment and outcome in 31 dogs with presumed primary colorectal lymphoma (2001–2013)

      I. Desmas, J. H. Burton, G. Post, O. Kristal, M. Gauthier, J. F. Borrego, A. Di Bella and A. Lara-Garcia

      Version of Record online: 29 MAR 2016 | DOI: 10.1111/vco.12194

    6. The use, publication and future directions of immunocytochemistry in veterinary medicine: a consensus of the Oncology-Pathology Working Group

      H. L. Priest, K. R. Hume, D. Killick, A. Kozicki, V. L. Rizzo, D. Seelig, L. A. Snyder, N. L. Springer, Z. M. Wright and C. Robat

      Version of Record online: 22 MAR 2016 | DOI: 10.1111/vco.12228

    7. The treatment of canine mast cell tumours with electrochemotherapy with or without surgical excision

      R. Lowe, A. Gavazza, J. A. Impellizeri, D. M. Soden and G. Lubas

      Version of Record online: 22 MAR 2016 | DOI: 10.1111/vco.12217

    8. Establishment and characterization of a canine soft tissue sarcoma patient-derived xenograft model

      J. P. Frazier, E. Beirne, S. H. Ditzler, I. Tretyak, J. R. Casalini, D. J. Thirstrup, S. Knoblaugh, J. G. Ward, C. D. Tripp and R. A. Klinghoffer

      Version of Record online: 18 MAR 2016 | DOI: 10.1111/vco.12215

    9. Treatment of advanced canine anal sac adenocarcinoma with hypofractionated radiation therapy: 77 cases (1999–2013)

      B. McQuown, M. A. Keyerleber, K. Rosen, M. C. McEntee and K. E. Burgess

      Version of Record online: 16 MAR 2016 | DOI: 10.1111/vco.12226

    10. A three-dimensional cell culture system as an in vitro canine mammary carcinoma model for the expression of connective tissue modulators

      T. C. Cardoso, S. S. Sakamoto, D. Stockmann, T. F. B. Souza, H. L. Ferreira, R. Gameiro, F. V. Vieira, M. J. Q. Louzada, A. L. Andrade and E. F. Flores

      Version of Record online: 15 MAR 2016 | DOI: 10.1111/vco.12202

    11. Melting curve analysis in canine lymphoma by calculating maximum fluorescence decrease

      I. Schöpper, S. Ohmura, B. Rütgen, H. Tsujimoto, K. Weber and J. Hirschberger

      Version of Record online: 9 MAR 2016 | DOI: 10.1111/vco.12200

    12. Immunological and angiogenic markers during metronomic temozolomide and cyclophosphamide in canine cancer patients

      S. Denies, L. Cicchelero, H. de Rooster, S. Daminet, I. Polis, I. Van de Maele and N. N. Sanders

      Version of Record online: 9 MAR 2016 | DOI: 10.1111/vco.12203

    13. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response

      M. M. Flórez, H. B. Fêo, G. N. da Silva, R. S. Yamatogi, A. J. Aguiar, J. P. Araújo Jr. and N. S. Rocha

      Version of Record online: 16 FEB 2016 | DOI: 10.1111/vco.12220

    14. Immune regulation of canine tumour and macrophage PD-L1 expression

      G. Hartley, E. Faulhaber, A. Caldwell, J. Coy, J. Kurihara, A. Guth, D. Regan and S. Dow

      Version of Record online: 4 FEB 2016 | DOI: 10.1111/vco.12197

    15. You have full text access to this OnlineOpen article
      Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours

      M. Cemazar, J. Ambrozic Avgustin, D. Pavlin, G. Sersa, A. Poli, A. Krhac Levacic, N. Tesic, U. Lampreht Tratar, M. Rak and N. Tozon

      Version of Record online: 3 FEB 2016 | DOI: 10.1111/vco.12208

    16. PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis

      S. Iussich, L. Maniscalco, A. Di Sciuva, B. Iotti, E. Morello, M. Martano, F. Gattino, P. Buracco and R. De Maria

      Version of Record online: 1 FEB 2016 | DOI: 10.1111/vco.12190

    17. Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas – a prospective study

      B. Børresen, L. N. Nielsen, L. R. Jessen, A. T. Kristensen, M. Fredholm and S. Cirera

      Version of Record online: 21 JAN 2016 | DOI: 10.1111/vco.12196

    18. Prognostic significance of Ki67 evaluated by flow cytometry in dogs with high-grade B-cell lymphoma

      A. Poggi, B. Miniscalco, E. Morello, F. Gattino, A. Delaude, L. Ferrero Poschetto, L. Aresu, M. E. Gelain, V. Martini, S. Comazzi and F. Riondato

      Version of Record online: 21 JAN 2016 | DOI: 10.1111/vco.12184

    19. A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma

      R. Finotello, J. Henriques, S. Sabattini, D. Stefanello, R. Felisberto, S. Pizzoni, R. Ferrari and L. Marconato

      Version of Record online: 21 JAN 2016 | DOI: 10.1111/vco.12193

    20. Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomas

      S. Guil-Luna, Y. Millán, J. De Andres, E. Rollón, V. Domingo, J. García-Macías, R. Sánchez-Céspedes and J. Martín de las Mulas

      Version of Record online: 19 JAN 2016 | DOI: 10.1111/vco.12175

    21. DNA damage is a feature of feline injection-site sarcoma

      S. Kang, T. Southard and K. R. Hume

      Version of Record online: 19 JAN 2016 | DOI: 10.1111/vco.12195

    22. Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumours

      T. P. Raposo, I. Pires, J. Prada, F. L. Queiroga and D. J. Argyle

      Version of Record online: 17 JAN 2016 | DOI: 10.1111/vco.12209

    23. Photodynamic detection of canine mammary gland tumours after oral administration of 5-aminolevulinic acid

      T. Osaki, I. Yokoe, S. Ogura, K. Takahashi, K. Murakami, K Inoue, M. Ishizuka, T. Tanaka, L. Li, A. Sugiyama, K. Azuma, Y. Murahata, T. Tsuka, N. Ito, T. Imagawa and Y. Okamoto

      Version of Record online: 14 JAN 2016 | DOI: 10.1111/vco.12213

    24. The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α

      D. Azakami, R. Nakahira, Y. Kato, M. Michishita, M. Kobayashi, E. Onozawa, M. Bonkobara, M. Kobayashi, K. Takahashi, M. Watanabe, K. Ishioka, T. Sako, K. Ochiai and T. Omi

      Version of Record online: 14 JAN 2016 | DOI: 10.1111/vco.12199

    25. Evaluation of optimal water fluoridation on the incidence and skeletal distribution of naturally arising osteosarcoma in pet dogs

      R. B. Rebhun, P. H. Kass, M. S. Kent, K. D. Watson, S. S. Withers, W. T. N. Culp and A. M. King

      Version of Record online: 14 JAN 2016 | DOI: 10.1111/vco.12188

  12. Review Articles

    1. You have free access to this content
      Germline gene polymorphisms predisposing domestic mammals to carcinogenesis

      K. Flisikowski, T. Flisikowska, A. Sikorska, A. Perkowska, A. Kind, A. Schnieke and M. Switonski

      Version of Record online: 17 NOV 2015 | DOI: 10.1111/vco.12186

  13. Original Articles

    1. Chronic lymphocytic leukemia transformation into high-grade lymphoma: a description of Richter's syndrome in eight dogs

      S. Comazzi, V. Martini, F. Riondato, A. Poggi, D. Stefanello, L. Marconato, F. Albonico and M. E. Gelain

      Version of Record online: 14 OCT 2015 | DOI: 10.1111/vco.12172

    2. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications

      F. L. Queiroga, M. D. Perez-Alenza, A. González-Gil, G. Silván, L. Peña and J. C. Illera

      Version of Record online: 14 OCT 2015 | DOI: 10.1111/vco.12174

    3. Comparison of chemotherapeutic drug resistance in cells transfected with canine ABCG2 or feline ABCG2

      R. S. Lewis, J. Fidel, S. Dassanayake, M. H. Court, N. S. Burke and K. L. Mealey

      Version of Record online: 14 OCT 2015 | DOI: 10.1111/vco.12177

  14. Review Articles

    1. You have free access to this content
      A descriptive review of cardiac tumours in dogs and cats

      E. Treggiari, B. Pedro, J. Dukes-McEwan, A. R. Gelzer and L. Blackwood

      Version of Record online: 30 SEP 2015 | DOI: 10.1111/vco.12167

  15. Original Articles

    1. Tumour necrosis factor-alpha-induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus

      J. A. Garcia, H. L. Ferreira, F. V. Vieira, R. Gameiro, A. L. Andrade, F. R. Eugênio, E. F. Flores and T. C. Cardoso

      Version of Record online: 16 SEP 2015 | DOI: 10.1111/vco.12168

    2. Clinical and computed tomography tumour dimension assessments for planning wide excision of injection site sarcomas in cats: how strong is the agreement?

      R. Ferrari, M. Di Giancamillo, D. Stefanello, C. Giudice, V. Grieco, M. Longo, G. Ravasio and P. Boracchi

      Version of Record online: 14 SEP 2015 | DOI: 10.1111/vco.12173

    3. Interactions between CXCR4 and CXCL12 promote cell migration and invasion of canine hemangiosarcoma

      K. S. Im, A. J. Graef, M. Breen, K. Lindblad-Toh, J. F. Modiano and J.-H. Kim

      Version of Record online: 3 SEP 2015 | DOI: 10.1111/vco.12165

    4. Feline discrete high-grade gastrointestinal lymphoma treated with surgical resection and adjuvant CHOP-based chemotherapy: retrospective study of 20 cases

      E. D. Gouldin, C. Mullin, M. Morges, S. J. Mehler, L.-P. de Lorimier, C. Oakley, R. Risbon, L. May, S. A. Kahn and C. Clifford

      Version of Record online: 3 SEP 2015 | DOI: 10.1111/vco.12166

    5. Post-radiotherapy hypothyroidism in dogs treated for thyroid carcinomas

      I. Amores-Fuster, P. Cripps and L. Blackwood

      Version of Record online: 24 AUG 2015 | DOI: 10.1111/vco.12162

    6. The animal-dependent risk factors in canine T-cell lymphomas

      U. Jankowska, D. Jagielski, M. Czopowicz and R. Sapierzyński

      Version of Record online: 24 AUG 2015 | DOI: 10.1111/vco.12164

    7. Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs

      C. M. Fulkerson, D. Dhawan, D. R. Jones, V. E. Marquez, P. A. Jones, Z. Wang, Q. Wu, J. E. Klaunig, L. M. Fourez, P. L. Bonney and D. W. Knapp

      Version of Record online: 14 JUL 2015 | DOI: 10.1111/vco.12159

    8. Nucleated erythrocytes in blood smears of dogs undergoing chemotherapy

      P. Moretti, A. Giordano, D. Stefanello, R. Ferrari, S. Castellano and S. Paltrinieri

      Version of Record online: 25 JUN 2015 | DOI: 10.1111/vco.12156

    9. Detection of monoclonality in intestinal lymphoma with polymerase chain reaction for antigen receptor gene rearrangement analysis to differentiate from enteritis in dogs

      S. Ohmura, M. Leipig, I. Schöpper, F. Hergt, K. Weber, B. C. Rütgen, H. Tsujimoto, W. Hermanns and J. Hirschberger

      Version of Record online: 18 MAY 2015 | DOI: 10.1111/vco.12151

    10. Combretastatin A4-phosphate and its potential in veterinary oncology: a review

      E. Abma, S. Daminet, P. Smets, Y. Ni and H. de Rooster

      Version of Record online: 18 MAY 2015 | DOI: 10.1111/vco.12150

  16. Invited Reviews

    1. You have free access to this content
      Canine brain tumours: a model for the human disease?

      J. Hicks, S. Platt, M. Kent and A. Haley

      Version of Record online: 18 MAY 2015 | DOI: 10.1111/vco.12152

  17. Original Articles

    1. Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog model

      K. Kicenuik, N. Northrup, A. Dawson, J. Locke, J. A. Villamil, J. Chretin, G. Sfiligoi, C. Clifford, M. Rosenberg, T. Hamilton, R. Regan, M. Parsons-Doherty, C. Mallett, J. Philibert, J. Impellizeri and E. Hofmeister

      Version of Record online: 10 APR 2015 | DOI: 10.1111/vco.12148

    2. Evaluation of the risks of chemotherapy in dogs with thrombocytopenia

      J. Finlay, K. Wyatt and M. Black

      Version of Record online: 10 APR 2015 | DOI: 10.1111/vco.12146

VIEW

  1. 1 - 100
  2. 101 - 127

SEARCH

SEARCH BY CITATION